Gradual dose reduction, when medically appropriate, is often considered preferable to stopping abruptly, since it gives the body more time to adjust to declining medication levels
Protein requires more energy to digest and provides sustained fuel compared to simple carbohydrates
(PubMed) Bryan HK, Olayanju A, Goldring CE, Park BK
Michael Palladinetti, global head of business development and licensing at Sanofi, told delegates attending Bio Europe Spring in Barcelona, Spain last week that history has shown us time and time again that no one has the monopoly on the next wave of innovation. Citing the recent GLP-1 wave, Palladinetti said the industry has a bit of fear of missing out (FOMO) and paid kudos to Lily and Novo for staying in the space. He added how innovation is also very difficult and that industry players need to have a broad view. Both firms are pioneers in the diabetes space, having launched their own versions of insulin over 100 years ago
Hypoglycaemia (low blood sugar) may occur, particularly when Mounjaro is used in combination with insulin or sulphonylureas